Skip to main content

What the FDA labels say about taking them together

Letermovir and phenobarbital

Letermovir's FDA label of January 14, 2026 names phenobarbital in its drug interactions section; the phenobarbital labels PlainMeds reads (2) do not name letermovir. The letermovir label: “Co-administration of PREVYMIS and phenobarbital is not recommended due to potential for loss of efficacy of PREVYMIS.”

Check it at the source: the letermovir FDA label on DailyMed (effective January 14, 2026, Merck Sharp & Dohme LLC); the phenobarbital FDA label on DailyMed (effective August 27, 2026).

What does the letermovir label say about phenobarbital?

Letermovir label, drug interactions

Concomitant Drug Class and/or Clearance Pathway/Drug Name: phenobarbital; Effect on Concentration ↓ =decrease, ↑ =increase: ↓ letermovir; Clinical Comments: Co-administration of PREVYMIS and phenobarbital is not recommended due to potential for loss of efficacy of PREVYMIS.

Source: FDA drug label (PREVYMIS), Merck Sharp & Dohme LLC, effective January 14, 2026 (SPL set 1b49df80-be4f-47e0-a0b7-123f3e69395b), via openFDA; the full label on DailyMed

What does the phenobarbital label say about letermovir?

Phenobarbital's label (effective August 27, 2026) and its 1 other brand-application label do not name letermovir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Phenobarbital), Chartwell RX, LLC, effective August 27, 2026 (SPL set 74428144-fb24-40a5-a670-3b876e2d116c), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Letermovir generic labelers
0Phenobarbital generic labelers
LetermovirPhenobarbital
Labeled forn/aSeizures and epilepsy
Boxed warningNoNo
Pharmacy cost (NADAC)n/a$0.213 per tablet 100 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?